References
- Kyle RA. Criteria for classification of monoclonal gammopathies, multiple myeloma and related disorders: a report of the International Myeloma Working Group. Br J Haematol 2003;121:749–757.
- Galieni P, Cavo M, Pulsoni A, et al Clinical outcome of extramedullary plasmacytoma. Haematologica 2000;85:47–51.
- Ozsahin M, Tsang RW, Poortmans P, et al Outcomes and patterns of failure in solitary plasmacytoma: a multicenter rare cancer network study of 258 patients. Int J Radiat Oncol Biol Phys 2006;64:210–217.
- Hussong JW, Perkins SL, Schnitzer B, Hargreaves H, Frizzera G. Extramedullary plasmacytoma. A form of marginal zone cell lymphoma? Am J Clin Pathol 1999;111:111–116.
- Rawstron AC, Orfao A, Beksac M, et al Report of the European Myeloma Network on multiparametric flow cytometry in multiple myeloma and related disorders. Haematologica 2008;93:431–438.
- Kremer M, Ott G, Nathrath M, et al Primary extramedullary plasmacytoma and multiple myeloma: phenotypic differences revealed by immunohistochemical analysis. J Pathol 2005;205:92–101.
- Yang F, Liu WP, Jiang LL, Li FY, Liao DY, Li GD. Solitary plasmacytoma: a clinicopathologic and immunophenotypic analysis of 43 cases. Sichuan Da Xue Xue Bao Yi Xue Ban 2006;37:93–96.
- Kojima M, Motoori T, Tamaki Y, et al Cyclin D1 protein overexpression in extramedullary plasmacytoma: a clinicopathologic study of 11 cases. J Clin Exp Hematop 2009;49:53–56.
- Menke DM, Horny H-P, Greisser H, et al Primary lymph node plasmacytomas (plasmacytic lymphomas). Am J Clin Pathol 2001;115:119–126.
- Seegmiller AC, Xu Y, McKenna RW, Karandikar NJ. Immunophenotypic differentiation between neoplastic plasma cells in mature B-cell lymphoma vs plasma cell myeloma. Am J Clin Pathol 2007;127:176–181.
- Aalto Y, Nordling S, Kivioja AH, Karaharju E, Elomaa I, Knuutila S. Among numerous DNA copy number changes, losses of chromosome 13 are highly recurrent in plasmacytoma. Genes Chromosomes Cancer 1999;25:104–107.
- Bink K, Haralambieva E, Kremer M, et al Primary extramedullary plasmacytoma: similarities with and differences from multiple myeloma revealed by interphase cytogenetics. Haematologica 2008;93:623–626.
- Hill QA, Rawstron AC, Child JA, De Tute RM, Owen RG. Neoplastic plasma cells are demonstrable at bone marrow sites distant to solitary plasmacytoma of bone and predict for progression to multiple myeloma. Br J Haematol 2007;137(Suppl. 1): Abstract 54.
- Kato T, Tsukamoto E, Nishioka T, et al Early detection of bone marrow involvement in extramedullary plasmacytoma by whole-body F-18 FDG positron emission tomography. Clin Nucl Med 2000;25:870–873.
- Avet-Loiseau H, Garand R, Lode L, Harousseau JL, Bataille R. Translocation t(11;14)(q13;q32) is the hallmark of IgM, IgE, and nonsecretory multiple myeloma variants. Blood 2003;101:1570–1571.
- Hedvat CV, Comenzo RL, Teruya-Feldstein J, et al Insights into extramedullary tumour cell growth revealed by expression profiling of human plasmacytomas and multiple myeloma. Br J Haematol 2003;122:728–744.